Breaking News Instant updates and real-time market news.

TMCX

Trinity Merger

$10.37

(0.00%)

08:21
08/12/19
08/12
08:21
08/12/19
08:21

Trinity Merger to acquire Broadmark for $1.2B in cash, stock transaction

Trinity Merger and Broadmark announced that they have entered into a definitive merger agreement for a business combination transaction to create an internally-managed, mortgage real estate investment trust, or REIT, with an expected equity value of $1.5B, assuming no redemptions by Trinity stockholders or Broadmark members. It is expected that Broadmark will have no debt outstanding at closing. Under the terms of the merger agreement, Trinity and Broadmark will combine to form Broadmark Realty, a new Maryland corporation that will elect to be taxed as a REIT under the tax code. In connection with the transaction, Broadmark Realty intends to apply for listing of its securities on the New York Stock Exchange under a new ticker symbol. Broadmark is a provider of financing to real estate investors and developers across the United States. Broadmark originates short term, first deed of trust mortgages with conservative loan-to-value collateral support. As of March 31, Broadmark had approximately $992.2M in total committed loans in target geographic regions that exhibit favorable demographic trends. Under the terms of the merger agreement, Trinity will acquire Broadmark for $1.2B in total consideration, comprised of 92%, or $1.1B, in Broadmark Realty stock and 8%, or $98M, in cash. The cash component of the purchase price will be paid to the equity owners of Broadmark's real estate management companies as part of an internalization transaction and will be funded by Trinity's cash held in trust. The remainder of the purchase price to be paid will be paid in newly issued shares of Broadmark Realty's common stock. In addition, Broadmark Realty has entered into a subscription agreement for a $75M private placement of Broadmark Realty's common stock with affiliates of Farallon, a global asset management firm. The proceeds from Farallon's investment will be used to fund transaction-related expenses and the ongoing business operations of Broadmark Realty following the consummation of the business combination, including funding new loan origination opportunities in existing and new markets. Upon closing of the proposed transaction, Jeffrey Pyatt, president of Pyatt Broadmark Management, will become the CEO of Broadmark Realty, and Joseph Schocken, founder and president of Broadmark Capital, will serve as chairman of the board of directors. The rest of Broadmark's executive team will continue in their respective roles in the combined company. The board of directors of Trinity and the boards of directors and managers of the Broadmark entities have unanimously approved the proposed transaction. Completion of the proposed transaction is subject to Trinity stockholder approval; Broadmark equity holder approval; obtaining an amendment to Trinity's outstanding public warrants to remove certain anti-dilution provisions relating to the payment of ordinary periodic cash dividends customary for a REIT; Broadmark Realty retaining at least $100M in cash following the consummation of the transactions, the redemption of Trinity shares, if any, and the payment of expenses and indebtedness required to be paid at the closing and other customary closing conditions. The parties expect that the proposed transaction will be completed in early November.

TODAY'S FREE FLY STORIES

BYND

Beyond Meat

$144.44

-0.49 (-0.34%)

08:06
08/20/19
08/20
08:06
08/20/19
08:06
Hot Stocks
C.A. Fortune announces National Sales Agency partnership with Beyond Meat »

C.A. Fortune announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTLK

Outlook Therapeutics

$1.95

-0.05 (-2.50%)

08:05
08/20/19
08/20
08:05
08/20/19
08:05
Hot Stocks
Outlook Therapeutics completes patient enrollment for NORSE 1 Phase 3 trial »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 12

    Sep

BTAI

BioXcel Therapeutics

$8.73

-0.5 (-5.42%)

08:04
08/20/19
08/20
08:04
08/20/19
08:04
Hot Stocks
BioXcel Therapeutics awarded grant by U.S. DoD for BXCL501 development »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLY

Soliton

$11.07

0.63 (6.03%)

08:03
08/20/19
08/20
08:03
08/20/19
08:03
Hot Stocks
Soliton announces results from preclinical studies of RAP treatment »

Soliton announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$2.71

(0.00%)

08:03
08/20/19
08/20
08:03
08/20/19
08:03
Hot Stocks
Mersana Therapeutics intitiates expansion portion of Phase 1 study of XMT-1536 »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGR

Eiger BioPharmaceuticals

$10.43

0.16 (1.56%)

08:02
08/20/19
08/20
08:02
08/20/19
08:02
Hot Stocks
Eiger BioPharmaceuticals receives FDA BTD for for peginterferon lambda »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIQT

LiqTech

$6.44

-0.81 (-11.17%)

08:02
08/20/19
08/20
08:02
08/20/19
08:02
Hot Stocks
LiqTech announces SPA to acquire BS Plastic »

LiqTech International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

CACI

CACI

$209.74

1.42 (0.68%)

08:01
08/20/19
08/20
08:01
08/20/19
08:01
Upgrade
CACI rating change  »

CACI upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VST

Vistra Energy

$23.68

-0.02 (-0.08%)

08:00
08/20/19
08/20
08:00
08/20/19
08:00
Hot Stocks
Vistra Energy to acquire Ambit Energy for $475M »

Vistra Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

CNHI

CNH Industrial

$9.37

0.555 (6.30%)

08:00
08/20/19
08/20
08:00
08/20/19
08:00
Options
CNH Industrial call buyer realizes 150% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$143.66

-0.23 (-0.16%)

07:59
08/20/19
08/20
07:59
08/20/19
07:59
Recommendations
Salesforce analyst commentary  »

Salesforce sets up for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:57
08/20/19
08/20
07:57
08/20/19
07:57
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$61.34

0.14 (0.23%)

07:55
08/20/19
08/20
07:55
08/20/19
07:55
Downgrade
Vornado rating change  »

Vornado downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

07:55
08/20/19
08/20
07:55
08/20/19
07:55
General news
U.S. chain store sales fell 0.2% in the week ended August 17 »

U.S. chain store sales…

ANAB

AnaptysBio

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Recommendations
AnaptysBio analyst commentary  »

Cantor says AnaptysBio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOVA

Sunnova Energy

$11.13

0.089 (0.81%)

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Initiation
Sunnova Energy initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:50
08/20/19
08/20
07:50
08/20/19
07:50
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

IMMU

Immunomedics

$14.83

-0.11 (-0.74%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Initiation
Immunomedics initiated  »

Cantor Fitzgerald starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

LVS

Las Vegas Sands

$54.67

2.28 (4.35%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Downgrade
Las Vegas Sands rating change  »

Las Vegas Sands cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SILK

Silk Road Medical

$40.85

0.28 (0.69%)

07:44
08/20/19
08/20
07:44
08/20/19
07:44
Initiation
Silk Road Medical initiated  »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

IQ

iQIYI

$18.10

1.02 (5.97%)

07:42
08/20/19
08/20
07:42
08/20/19
07:42
Downgrade
iQIYI rating change  »

iQIYI downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNET

ChinaNet Online

$1.50

0.135 (9.89%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Hot Stocks
ChinaNet CEO says will continue to integrate blockchain, AI tech into products »

CEO Handong Cheng,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:37
08/20/19
08/20
07:37
08/20/19
07:37
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

VVUS

VIVUS

$3.46

-0.02 (-0.57%)

07:36
08/20/19
08/20
07:36
08/20/19
07:36
Hot Stocks
VIVUS says study shows addition of Qsymia to LSG surgery improved weight loss »

VIVUS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.